-
1 Comment
HealthEquity, Inc is currently in a long term uptrend where the price is trading 12.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.0.
HealthEquity, Inc's total revenue sank by 6.5% to $188M since the same quarter in the previous year.
Its net income has increased by 2924.7% to $5M since the same quarter in the previous year.
Finally, its free cash flow grew by 190.9% to $59M since the same quarter in the previous year.
Based on the above factors, HealthEquity, Inc gets an overall score of 4/5.
ISIN | US42226A1079 |
---|---|
CurrencyCode | EUR |
Exchange | F |
Sector | Healthcare |
Industry | Health Information Services |
Dividend Yield | 0.0% |
---|---|
Target Price | 85.5 |
PE Ratio | None |
Beta | 0.8 |
Market Cap | 5B |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2HE.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024